Omeprazole Export Market Intelligence: India's 975 Suppliers Shipping to 179 Countries — TransData Nexus 2026

Q: Who are the top omeprazole exporters from India?

The top omeprazole exporters from India are: 1. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $170.0M (26.8% market share); 2. CIPLA LIMITED — $120.2M (18.9% market share); 3. DR.REDDY'S LABORATORIES LTD — $46.3M (7.3% market share); 4. MICRO LABS LIMITED — $37.9M (6.0% market share); 5. MYLAN LABORATORIES LIMITED — $33.8M (5.3% market share). Together they account for 64.2% of India's total omeprazole export value.

Q: What is the total export value of omeprazole from India?

The total export value of omeprazole from India is $635.6M USD, recorded across 15,000 shipment transactions from 975 active exporters to 179 destination countries. The average shipment value is $42.4K.

Q: Which countries import omeprazole from India?

India exports omeprazole to 179 countries worldwide. The top importing countries are: UNITED STATES (26.0% share, $165.2M), CANADA (13.5% share, $85.9M), BELGIUM (10.1% share, $64.2M), YEMEN (8.1% share, $51.7M), VIETNAM (6.8% share, $43.0M). These five markets account for 64.5% of total export value.

Q: What is the HS code for omeprazole exports from India?

The primary HS code for omeprazole exports from India is 30049034. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of omeprazole exports from India?

The average unit price for omeprazole exports from India is $49.82 USD per unit, with prices ranging from $0.00 to $3970.95 depending on formulation, packaging, and order volume. The total market is valued at $635.6M across 15,000 shipments.

Q: Which ports handle omeprazole exports from India?

The primary ports for omeprazole exports from India are NHAVA SHEVA SEA (INNSA1) (12.7% of shipments), SAHAR AIR CARGO ACC (INBOM4) (8.8% of shipments), DELHI AIR CARGO ACC (INDEL4) (5.7% of shipments), SAHAR AIR (5.6% of shipments), JNPT/ NHAVA SHEVA SEA (5.2% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of omeprazole?

India is one of the world's leading exporters of omeprazole due to its large base of 975 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports omeprazole to 179 countries, demonstrating 92% global market coverage.

Q: What certifications do Indian omeprazole exporters need?

Indian omeprazole exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import omeprazole from India?

There are 2,858 registered buyers importing omeprazole from India, spread across 179 countries. The repeat buyer rate is 59.0%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top omeprazole supplier from India?

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading omeprazole exporter from India with a market share of 26.8% and total export value of $170.0M across 1073 shipments. The top 5 suppliers together control 64.2% of total export value.

Suresh Sormare

Omeprazole

India Pharmaceutical Trade Intelligence

$635.6M975 Suppliers179 CountriesHS 30049034

ExportsIndia → UNITED STATES26.0%India → CANADA13.5%

ImportsCANADA → India$3.4M GERMANY → India$52.0K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: YUSEN LOGISTICS

Omeprazole Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Omeprazole to the World

Between 2022 and 2026, India exported $635.6M worth of omeprazole across 15,000 verified shipments to 179 countries — covering 92% of world markets in the Gastrointestinal segment. The largest destination is UNITED STATES (26.0%). SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 26.8% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published May 2026·Updated May 2026·

Omeprazole export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Omeprazole export data snapshot — $635.6M · 975 exporters · 179 countriesTransData Nexus · Indian Customs Data

Top Omeprazole Exporters from India

975 active exporters · Ranked by export value

View all 975 →

Top Omeprazole Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$170.0M	1,073	19	26.8%
2	CIPLA LIMITED

Top Countries Importing Omeprazole from India

179 destination markets · Ranked by import value

All 179 countries →

Top Countries Importing Omeprazole from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$165.2M	26.0%
2	CANADA	$85.9M	13.5%
3	BELGIUM	$64.2M	10.1%
4	YEMEN	$51.7M	8.1%
5	VIETNAM	$43.0M	6.8%
6	AUSTRALIA	$25.2M	4.0%
7	SOUTH AFRICA	$17.2M	2.7%
8	KENYA	$16.3M	2.6%
9	BRAZIL	$14.3M	2.3%
10	CHILE	$9.9M	1.6%

UNITED STATES is India's largest omeprazole export destination, absorbing 26.0% of total exports worth $165.2M. The top 5 importing countries — UNITED STATES, CANADA, BELGIUM, YEMEN, VIETNAM — together account for 64.5% of India's total omeprazole export value. The remaining 174 destination countries collectively receive the other 35.5%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Omeprazole to India?

26 origin countries · Total import value: $361.4B

India imports omeprazole from 26 countries with a combined import value of $361.4B. The largest supplier is SPAIN ($361.4B, 88 shipments), followed by CANADA and UNITED STATES. All values are from Indian Customs (DGFT) import records.

Countries Supplying Omeprazole to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	SPAIN	$361.4B	88	100.0%
2	CANADA	$3.4M	49	0.0%
3	UNITED STATES	$654.5K	256	0.0%
4	UNITED KINGDOM	$72.9K	37	0.0%
5	GERMANY	$52.0K	24	0.0%
6	YEMEN	$40.6K	1	0.0%
7	BULGARIA	$24.3K	25	0.0%
8	NETHERLANDS	$21.3K	10	0.0%
9	AUSTRALIA	$11.3K	10	0.0%
10	ISRAEL	$11.0K	9	0.0%

Showing top 10 of 26 origin countries

SPAIN is the largest supplier of omeprazole to India, accounting for 100.0% of total import value. The top 5 origin countries — SPAIN, CANADA, UNITED STATES, UNITED KINGDOM, GERMANY — together supply 100.0% of India's omeprazole imports. Click any country to see detailed supplier and buyer data for that import corridor.

Omeprazole — Export Intelligence Video

Visual overview of India's omeprazole import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's omeprazole pharmaceutical import and export market — $635.6M in total trade, 975 verified manufacturers, and 179 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Omeprazole

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Omeprazole has been extensively approved in the United States through Abbreviated New Drug Applications (ANDAs). For instance, Sun Pharmaceutical Industries Limited received approval for ANDA 207891 on May 30, 2018, for Omeprazole Delayed-Release Tablets, 20 mg (OTC). This approval granted Sun Pharmaceutical 180 days of generic drug exclusivity, commencing from the date of commercial marketing.

The regulatory pathway for Omeprazole in the U.S. involves demonstrating bioequivalence to the reference listed drug, as outlined in the FDA's Orange Book. Given the presence of 975 active Indian exporters and a buyer count of 2,858, with a repeat buyer rate of 59.0%, the competitive landscape underscores the importance of strict adherence to FDA regulations to maintain market access.

2EU & UK Regulatory Framework

In the European Union, Omeprazole is subject to marketing authorization by the European Medicines Agency (EMA). A notable example is the approval of Omeprazole TriviumVet, a veterinary medicinal product, on April 15, 2025. (ema.europa.eu) The EMA's Committee for Medicinal Products for Human Use (CHMP) has also conducted referrals to harmonize product information across member states, as seen with the Losec (omeprazole) referral concluded on June 10, 2010. (ema.europa.eu)

In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) oversees the approval and monitoring of Omeprazole products. For instance, on June 30, 2025, the MHRA issued a Class 3 Medicines Recall for Omeprazole 20 mg/15 ml Oral Solution by Glenmark Pharmaceuticals Europe Ltd due to product quality concerns. (gov.uk)

Compliance with EU Good Manufacturing Practice (GMP) requirements is mandatory for manufacturers exporting to these regions. The presence of 179 destination countries for Indian Omeprazole exports highlights the necessity for exporters to align with diverse regulatory standards.

3WHO Essential Medicines & Global Standards

Omeprazole is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its significance in global health. The drug is also subject to international pharmacopoeia standards, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). Adherence to these standards ensures the quality and efficacy of Omeprazole across different markets.

4India Regulatory Classification

In India, Omeprazole is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates its pricing under the Drug Price Control Order (DPCO). As of March 2026, the ceiling price for Omeprazole 20 mg capsules is set at ₹5.00 per capsule. Exporters are required to obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of pharmaceutical products, ensuring compliance with national regulations.

5Patent & Exclusivity Status

The primary patents for Omeprazole have expired, leading to significant generic competition globally. This competitive environment is reflected in the average Free on Board (FOB) unit price of $49.82 for Indian exports. Exporters must navigate this landscape by ensuring compliance with international regulatory standards and maintaining competitive pricing strategies.

6Recent Industry Developments

In June 2025, the MHRA issued a Class 3 Medicines Recall for Omeprazole 20 mg/15 ml Oral Solution by Glenmark Pharmaceuticals Europe Ltd due to product quality concerns. (gov.uk)

In April 2025, the EMA approved Omeprazole TriviumVet, a veterinary medicinal product, expanding the scope of Omeprazole's applications within the EU market. (ema.europa.eu)

In March 2026, the NPPA revised the ceiling price for Omeprazole 20 mg capsules to ₹5.00 per capsule, impacting pricing strategies for domestic manufacturers and exporters.

In February 2026, the WHO updated its Model List of Essential Medicines, reaffirming the inclusion of Omeprazole, highlighting its continued importance in global healthcare.

In January 2026, the CDSCO issued new guidelines for the export of pharmaceutical products, emphasizing the need for stringent quality control measures, directly affecting Omeprazole exporters.

These developments underscore the dynamic regulatory environment surrounding Omeprazole, necessitating continuous monitoring and compliance by exporters to maintain market access and competitiveness.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Omeprazole

Retail & reference prices across 9 markets vs. India FOB export price of $49.82/unit

Global Price Benchmark for Omeprazole across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.50	USD	According to the FDA's Orange Book, Omeprazole is available as a generic medication, contributing to its affordability.
United Kingdom	$0.40	GBP	The NHS Drug Tariff lists Omeprazole 20 mg capsules, indicating its inclusion in the standard reimbursement list.
Germany	$0.38	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) includes Omeprazole in its list of approved medications, reflecting its regulated status.
Australia	$0.45

Supply Chain Risk Assessment — Omeprazole

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Omeprazole, a widely used proton pump inhibitor, is primarily manufactured in India, which has established itself as a significant producer of Active Pharmaceutical Ingredients (APIs). However, the production of these APIs is heavily reliant on Key Starting Materials (KSMs) imported from China. This dependency poses a substantial risk, as any disruption in the supply of KSMs can halt API production, leading to shortages of the final pharmaceutical product. According to the U.S. Pharmacopeia, 41% of KSMs used in U.S.-approved APIs are solely sourced from China, highlighting the critical nature of this supply chain vulnerability.

Recent events have underscored this risk. In October 2025, the U.S. Pharmacopeia reported that 58% of KSMs used for U.S.-approved APIs are sole sourced from a single country, with 41% from China and 16% from India. This concentration increases the potential for supply chain disruptions, emphasizing the need for diversification in sourcing strategies.

2Supplier Concentration & Single-Source Risk

The export data for Omeprazole from India reveals a high level of supplier concentration. The top five exporters—Sun Pharmaceutical Industries Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd, Micro Labs Limited, and Mylan Laboratories Limited—account for 64.2% of the total export value. Sun Pharmaceutical Industries Limited alone contributes 26.8% of the exports. This concentration indicates a significant single-source risk; any operational or regulatory issues affecting these key suppliers could disrupt the global supply of Omeprazole.

Access Complete Omeprazole Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 15,000 transactions across 179 markets.

Request Demo View Pricing

Frequently Asked Questions — Omeprazole Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top omeprazole exporters from India?

The leading omeprazole exporters from India are SUN PHARMACEUTICAL INDUSTRIES LIMITED, CIPLA LIMITED, DR.REDDY'S LABORATORIES LTD, and 12 others. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 26.8% market share ($170.0M). The top 5 suppliers together control 64.2% of total export value.

What is the total export value of omeprazole from India?

The total export value of omeprazole from India is $635.6M, recorded across 15,000 shipments from 975 active exporters to 179 countries. The average shipment value is $42.4K.

Which countries import omeprazole from India?

India exports omeprazole to 179 countries. The top importing countries are UNITED STATES (26.0%), CANADA (13.5%), BELGIUM (10.1%), YEMEN (8.1%), VIETNAM (6.8%), which together account for 64.5% of total export value.

What is the HS code for omeprazole exports from India?

The primary HS code for omeprazole exports from India is 30049034. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Omeprazole

Omeprazole

Top Omeprazole Exporters from India

Top Countries Importing Omeprazole from India

Who Supplies Omeprazole to India?

Quick Facts

Related Gastrointestinal

Related Analysis

Need Details?

Omeprazole — Export Intelligence Video

Regulatory Landscape — Omeprazole

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Omeprazole

Supply Chain Risk Assessment — Omeprazole

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Omeprazole Trade Intelligence

Frequently Asked Questions — Omeprazole Exports from India

Who are the top omeprazole exporters from India?

What is the total export value of omeprazole from India?

Which countries import omeprazole from India?

What is the HS code for omeprazole exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of omeprazole exports from India?

Which ports handle omeprazole exports from India?

Why is India a leading exporter of omeprazole?

What certifications do Indian omeprazole exporters need?

How many buyers import omeprazole from India?

What is the market share of the top omeprazole exporter from India?

Analysis Methodology